Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day
08 Juillet 2024 - 12:59PM
Business Wire
Bristol Myers Squibb (NYSE: BMY) today announced that the
company will participate in Virtual Targeted Protein Degradation
Day hosted by UBS.
Robert Plenge, M.D., Ph.D., Executive Vice President, Chief
Research Officer and Head of Research, will take part in a fireside
chat on Monday, July 15, 2024. He will answer questions about the
company beginning at 11:00 a.m. ET.
Investors and the general public are invited to listen to a live
webcast of the session by visiting http://investor.bms.com. An
archived edition of the session will be available following its
conclusion.
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop, and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, X (formerly Twitter), YouTube, Facebook, and
Instagram.
corporatefinancial-news
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240708499477/en/
Media: media@bms.com
Investors: investor.relations@bms.com
Bristol Myers Squibb (NYSE:BMY)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Bristol Myers Squibb (NYSE:BMY)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024
